Industry Voices

Today we introduce another name to our list of Industry Voices editors. Rhonda Greenapple is the president and founder of Reimbursement Intelligence, a consulting firm serving early stage biotech and the investment community. Before founding the group, Rhonda built a nationally recognized leadership team as President of the Managed Markets division of McCann Healthcare. Her experience includes the managed care and reimbursement execution from blockbusters to orphan drugs

For more information about the survey discussed in this article or to receive the RI Monitor Newsletter, visit

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.